Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Stefano Pergolizzi is a leading expert in stereotactic radiosurgery and radiotherapy, with a particular focus on robotic platforms for treating complex oncologic and vascular conditions. His research has significantly advanced the application of high-dose, precisely targeted radiation, demonstrating its efficacy as a non-invasive alternative to traditional surgery and brachytherapy. A landmark contribution is his work on high-dose robotic stereotactic body radiotherapy (SBRT) for localized prostate cancer, a study that has garnered 21 citations and established a critical framework for emulating high-dose-rate brachytherapy dose fractionation. Dr. Pergolizzi has also made substantial contributions to neuro-oncology, evidenced by his 14-cited analysis of prognostic factors in 223 patients treated with stereotactic image-guided radiosurgery for brain metastases. More recently, his 2022 study on image-guided robotic radiosurgery for cerebral arteriovenous malformations (AVMs) addresses a critical gap in the literature, providing vital clinical and radiographic outcome data for these challenging lesions. Through these works, Dr. Pergolizzi has consistently pushed the boundaries of precision radiation, improving treatment paradigms and patient outcomes across multiple disease sites.